Cargando…

Natural Killer Cells From Children With Type 1 Diabetes Have Defects in NKG2D-Dependent Function and Signaling

OBJECTIVE: Natural killer (NK) cells from NOD mice have numeric and functional abnormalities, and restoration of NK cell function prevents autoimmune diabetes in NOD mice. However, little is known about the number and function of NK cells in humans affected by type 1 diabetes. Therefore, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Huilian, Lee, I-Fang, Panagiotopoulos, Constadina, Wang, Xiaoxia, Chu, Alvina D., Utz, Paul J., Priatel, John J., Tan, Rusung
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Immunology and Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046846/ https://www.ncbi.nlm.nih.gov/pubmed/21270236 http://dx.doi.org/10.2337/db09-1706

Ejemplares similares

Natural killer T cell strategies to combat Epstein–Barr virus infection
por: Priatel, John J, et al.
Publicado: (2014)

CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections
por: Chung, Brian K., et al.
Publicado: (2015)

Deciphering the biology of NKG2C+ natural killer cells
por: Rölle, Alexander
Publicado: (2015)

Activation status dictates the function of unlicensed natural killer cells in mice and humans
por: Aguilar, Ethan G., et al.
Publicado: (2021)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D
por: Sayitoglu, Ece Canan, et al.
Publicado: (2020)

NKG2C(+)NKG2A(−) Natural Killer Cells are Associated with a Lower Viral Set Point and may Predict Disease Progression in Individuals with Primary HIV Infection
por: Ma, Meichen, et al.
Publicado: (2017)

Emergence of human CMV-induced NKG2C(+) NK cells is associated with CD8(+) T-cell recovery after allogeneic HCT
por: van der Ploeg, Kattria, et al.
Publicado: (2023)

Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
por: Carapito, Raphael, et al.
Publicado: (2017)

Adaptive NKG2C(+)CD57(+) Natural Killer Cell and Tim-3 Expression During Viral Infections
por: Kared, Hassen, et al.
Publicado: (2018)

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Natural killer cell NKG2D and granzyme B are critical for allergic pulmonary inflammation(⋆)
por: Farhadi, Nazanin, et al.
Publicado: (2014)

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome
por: Vietzen, Hannes, et al.
Publicado: (2022)

New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
por: Hosomi, Shuhei, et al.
Publicado: (2018)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy
por: Richard, Caroline, et al.
Publicado: (2017)

CXCR6(+) and NKG2C(+) Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation
por: Aviles-Padilla, Kevin, et al.
Publicado: (2022)

Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
por: Stone, Virginia M., et al.
Publicado: (2021)

NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia
por: Chang, Ming-Chin, et al.
Publicado: (2019)

NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Efficient Killing of Murine Pluripotent Stem Cells by Natural Killer (NK) Cells Requires Activation by Cytokines and Partly Depends on the Activating NK Receptor NKG2D
por: Gröschel, Carina, et al.
Publicado: (2017)

Defective Differentiation of Regulatory FoxP3(+) T Cells by Small-Intestinal Dendritic Cells in Patients With Type 1 Diabetes
por: Badami, Ester, et al.
Publicado: (2011)

Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
por: Campbell-Thompson, Martha, et al.
Publicado: (2016)

Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes
por: Ferraro, Alessandra, et al.
Publicado: (2011)

All-trans Retinoic Acid Inhibits Type 1 Diabetes by T Regulatory (Treg)-Dependent Suppression of Interferon-γ–Producing T-cells Without Affecting Th17 Cells
por: Van, Yang-Hau, et al.
Publicado: (2009)

A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement
por: Wang, Xiaoli, et al.
Publicado: (2018)

Should donors who have used marijuana be considered candidates for living kidney donation?
por: Ruckle, David, et al.
Publicado: (2018)

HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function
por: Garrido, Carolina, et al.
Publicado: (2016)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015)

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content
por: Dobbs, Kerry, et al.
Publicado: (2017)

B-Cell Cross-Presentation of Autologous Antigen Precipitates Diabetes
por: Mariño, Eliana, et al.
Publicado: (2012)

IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells
por: Abel, Alex M., et al.
Publicado: (2018)

Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice : The Paradox in Transgenic Models
por: Wang, Chia-Jen, et al.
Publicado: (2008)

The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2020)

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content
por: Dobbs, Kerry, et al.
Publicado: (2017)

Nardilysin-Dependent Proteolysis of Cell-Associated VTCN1 (B7-H4) Marks Type 1 Diabetes Development
por: Radichev, Ilian A., et al.
Publicado: (2014)

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2017)

Simultaneous Islet and Kidney Transplantation in Seven Patients With Type 1 Diabetes and End-Stage Renal Disease Using a Glucocorticoid-Free Immunosuppressive Regimen With Alemtuzumab Induction
por: Tan, Jianming, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_12r2otdqrg11nkh0seh95o5hku